Hindustan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
- Paid Up Capital ₹ 49.86 Cr
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.00 Cr
- Satisfied Charges ₹ 70.00 Cr
- Revenue Growth 22.29%
- Profit Growth 15.36%
- Ebitda 31.23%
- Net Worth 28.64%
- Total Assets 19.12%
About Hindustan Laboratories
Hindustan Laboratories Limited (HLL) is a Public Limited Indian Non-Government Company incorporated in India on 14 June 2017 (Seven years and eight months 10 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 49.86 Cr.
The company currently has active open charges totaling ₹50.00 Cr. The company has closed loans amounting to ₹70.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hindustan Laboratories Limited India are Subhash Ruia as CFO and Darshita Shah as Company Secretary. Rajesh Doshi, Kunjal Dedhia, Vijay Gadhia, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2017PLC296158
- Company No.
296158
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hindustan Laboratories?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajesh Doshi ![]() | Managing Director | 14-Jun-2017 | Current |
Subhash Ruia | CFO | 08-Oct-2020 | Current |
Darshita Shah | Company Secretary | 01-Jan-2022 | Current |
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kunjal Dedhia ![]() | Director | 14-Jun-2017 | Current |
Vijay Gadhia ![]() | Director | 14-Jun-2017 | Current |
Bhavik Sanghavi ![]() | Director | 17-Jan-2024 | Current |
Brijendrakumar Shukla ![]() | Director | 11-Mar-2024 | Current |
Ishika Bansal ![]() | Director | 17-Jan-2024 | Current |
Financial Performance of Hindustan Laboratories.
Hindustan Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.29% increase. The company also saw a substantial improvement in profitability, with a 15.36% increase in profit. The company's net worth Soared by an impressive increase of 28.64%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hindustan Laboratories?
In 2023, Hindustan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹50.00 Cr
₹70.00 Cr
Charges Breakdown by Lending Institutions
- Others : 50.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
09 Aug 2023 | Others | ₹35.00 Cr | Open |
09 Aug 2023 | Others | ₹15.00 Cr | Open |
16 Sep 2021 | Hdfc Bank Limited | ₹35.00 Cr | Satisfied |
28 Oct 2020 | Others | ₹35.00 Cr | Satisfied |
How Many Employees Work at Hindustan Laboratories?
Hindustan Laboratories has a workforce of 104 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hindustan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.